Evidence mapPaperPMID 41217104Full record

SynthesisJournal of primary care & community health

Efficacy of Community-based Interventions in Reducing HbA1c Levels Among Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Recent Studies Conducted in Developing Countries.

Lutfian Lutfian, Izdihar Javier Wardika, Muhammad Amirul Mukminin, Ibnu Syarifudin Hidayat, Riki Wartakusumah, Hatifah Ihsanda Tien Melati, Dinar Perwitasari, Fahmi Wildana, Nur Widayati, Fulgence Niyibitegeka and 1 more

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Journal of primary care & community health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lutfian LutfianMonash University, Clayton, VIC, Australia.ORCID 0000-0002-3154-1999
Izdihar Javier WardikaUniversitas Gadjah Mada, Yogyakarta, Indonesia.ORCID 0000-0002-4193-0883
Muhammad Amirul MukmininTaipei Medical University, Taiwan.ORCID 0000-0001-5246-1122
Ibnu Syarifudin HidayatMonash University, Clayton, VIC, Australia.ORCID 0000-0001-9165-0292
Riki WartakusumahKanazawa University, Ishikawa, Japan.ORCID 0000-0002-4241-0150
Hatifah Ihsanda Tien MelatiMonash University, Clayton, VIC, Australia.
Dinar PerwitasariMonash University, Clayton, VIC, Australia.
Fahmi WildanaUniversitas Jember, Indonesia.
Nur WidayatiUniversitas Jember, Indonesia.
Fulgence NiyibitegekaMinistry of Health, Bujumbura, Burundi.
Jonathan Hasian HaposanUniversitas Gadjah Mada, Yogyakarta, Indonesia.ORCID 0000-0002-3455-6379

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundType 2 Diabetes Mellitus (T2DM) presents a significant public health challenge, particularly in developing countries, where healthcare resources are limited. Community-Based Interventions (CBIs) have been explored as a strategy to improve glycemic control, yet evidence regarding their efficacy in reducing HbA1c levels in these settings remains limited.

aimThis study aimed to evaluate the efficacy of community-based interventions in improving HbA1c levels among patients with T2DM in developing countries.

methodsA systematic review and meta-analysis were performed following PRISMA guidelines. A comprehensive literature search was conducted in PubMed, Scopus, Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science, Ovid-Medline, and Cumulative Index to Nursing and Allied Health Literature (CINAHL) databases for full-text randomized controlled trials (RCTs) published between 2015 and 2024. Studies conducted in developing countries focusing on community-based interventions targeting HbA1c outcomes were included. Quality appraisal was conducted using the Joanna Briggs Institute (JBI) critical appraisal tools. Statistical analysis employed a random-effects model to calculate the pooled mean difference (MD) with 95% confidence intervals (CI). Heterogeneity was assessed using the

resultsTwenty RCTs involving 4914 participants across developing countries were included. CBIs significantly reduced HbA1c levels compared to usual care, with a pooled MD of -0.54 (95% CI = -0.71, -0.36;

conclusionCBIs are an effective strategy for reducing HbA1c levels among patients with T2DM in developing countries, with significant benefits across diverse economic contexts and intervention models. These findings highlight the adaptability and scalability of CBIs, underscoring their potential to enhance diabetes management in resource-limited settings.

Indexed as

Community Health ServicesDeveloping CountriesDiabetes Mellitus, Type 2Glycated HemoglobinHumansRandomized Controlled Trials as TopicGlycated Hemoglobinhemoglobin A1c protein, humancommunity-based interventionsdeveloping countriesglycemic controlHbA1ctype 2 diabetes mellitus

Identifiers

PMID41217104
PMCPMC12605876

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.